Long-term safety of enzyme replacement therapy with agalsidase alfa in patients with Fabry disease: post-marketing extension surveillance in Japan
| Autor: | Arakawa, Makoto, Ikeda, Yoshinori, Otaka, Hiromichi, Iwashiro, Sanghun |
|---|---|
| Zdroj: | In Molecular Genetics and Metabolism Reports September 2024 40 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|